Page last updated: 2024-09-05

lapatinib and Neuroblastoma

lapatinib has been researched along with Neuroblastoma in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Carter, DR; Chen, J; Cheung, BB; Ciampa, OC; Fletcher, JI; Ho, N; Kamili, A; Liu, PY; Liu, T; Marshall, GM; Sun, Y; Tee, AE; Wong, M	1
Brunak, S; Halasz, M; Huber, KVM; Kolch, W; Papamarkou, T; Radic-Sarikas, B; Superti-Furga, G; Tsafou, KP; Winter, GE	1

Other Studies

2 other study(ies) available for lapatinib and Neuroblastoma

Article	Year
Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma. International journal of cancer, 2020, 10-01, Volume: 147, Issue:7 Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lapatinib; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phenylenediamines; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; RNA-Binding Proteins	2020
Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter. Scientific reports, 2017, 06-08, Volume: 7, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Synergism; Humans; Imidazoles; Lapatinib; N-Myc Proto-Oncogene Protein; Naphthoquinones; Neuroblastoma; Protein Kinase Inhibitors; Receptor, trkA; RNA Interference; Zebrafish	2017

Article

Year

Combination therapy with the CDK7 inhibitor and the tyrosine kinase inhibitor exerts synergistic anticancer effects against MYCN-amplified neuroblastoma.

International journal of cancer, 2020, 10-01, Volume: 147, Issue:7

Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Gene Amplification; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Lapatinib; N-Myc Proto-Oncogene Protein; Neuroblastoma; Phenylenediamines; Protein Kinase Inhibitors; Pyridazines; Pyrimidines; RNA-Binding Proteins

2020

Lapatinib potentiates cytotoxicity of YM155 in neuroblastoma via inhibition of the ABCB1 efflux transporter.

Scientific reports, 2017, 06-08, Volume: 7, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Synergism; Humans; Imidazoles; Lapatinib; N-Myc Proto-Oncogene Protein; Naphthoquinones; Neuroblastoma; Protein Kinase Inhibitors; Receptor, trkA; RNA Interference; Zebrafish

2017